Journal of Clinical Investigation · 2024 · 22 citations · 56 references
Life SciencesImmunologyPathobiologyInflammationInnate ImmunityTransplant ImmunologyB Cell BiologyB Cell Receptor SignalingB-cell ResponsesHumoral ImmunityInflammatory SignalingPulmonary InflammationB Cell InfiltrationB Cell-mediated ImmunityB-cell Mediated ImmunityCell InfiltrationIntravital MicroscopyIschemia-reperfusion Lung InjuryMonocyte InfiltrationNeutrophil Extravasation
Ischemia/reperfusion injury-mediated (IRI-mediated) primary graft dysfunction (PGD) adversely affects both short- and long-term outcomes after lung transplantation, a procedure that remains the only treatment option for patients suffering from end-stage respiratory failure. While B cells are known to regulate adaptive immune responses, their role in lung IRI is not well understood. Here, we demonstrated by intravital imaging that B cells are rapidly recruited to injured lungs, where they extravasate into the parenchyma. Using hilar clamping and transplant models, we observed that lung-infiltrating B cells produce the monocyte chemokine CCL7 in a TLR4-TRIF-dependent fashion, a critical step contributing to classical monocyte (CM) recruitment and subsequent neutrophil extravasation, resulting in worse lung function. We found that synergistic BCR-TLR4 activation on B cells is required for the recruitment of CMs to the injured lung. Finally, we corroborated our findings in reperfused human lungs, in which we observed a correlation between B cell infiltration and CM recruitment after transplantation. This study describes a role for B cells as critical orchestrators of lung IRI. As B cells can be depleted with currently available agents, our study provides a rationale for clinical trials investigating B cell-targeting therapies.
56
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
Frederick L. Locke, David B. Miklos, Caron A. Jacobson et al. · New England Journal of Medicine · 2021 · 1.5K citations · Full text
Medicine, Hematology, Oncology +8
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
Jesús F. San Miguel, Binod Dhakal, Kwee Yong et al. · New England Journal of Medicine · 2023 · 733 citations · Full text
Medicine, Oncology, Pharmacotherapy +17